Trade PBYI anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Puma Biotechnology Inc (PBYI) is trading at US$9.13, down 1.20% today as of Aug 28, 10:57 EDT. The company has a market capitalisation of US$476.97M. Over the past 52 weeks, PBYI has traded between US$4.30 and US$9.51. On Syfe you can trade PBYI with $0 commission and add it to your watchlist.
| Previous close | US$9.24 |
|---|---|
| Market cap | US$476.97M |
| 52-week range | US$4.30 – US$9.51 |
| Volume | 202.72K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Puma Biotechnology Inc
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
Year: 2012
Puma Biotechnology Inc (PBYI) stock is trading at US$9.13, -1.20% from the previous close of US$9.24.
The market cap for Puma Biotechnology Inc (PBYI) stock is approximately US$476.97M.
The 52-week high for Puma Biotechnology Inc (PBYI) stock is US$9.51.
The 52-week low for Puma Biotechnology Inc (PBYI) stock is US$4.30.
Puma Biotechnology Inc (PBYI) does not currently pay a dividend.
Stay on top of PBYI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
